11-64234864-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003377.5(VEGFB):c.31G>A(p.Ala11Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,294,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003377.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VEGFB | NM_003377.5 | c.31G>A | p.Ala11Thr | missense_variant | 1/7 | ENST00000309422.7 | NP_003368.1 | |
VEGFB | NM_001243733.2 | c.31G>A | p.Ala11Thr | missense_variant | 1/7 | NP_001230662.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VEGFB | ENST00000309422.7 | c.31G>A | p.Ala11Thr | missense_variant | 1/7 | 1 | NM_003377.5 | ENSP00000311127 | ||
VEGFB | ENST00000426086.3 | c.31G>A | p.Ala11Thr | missense_variant | 1/7 | 1 | ENSP00000401550 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000200 AC: 3AN: 149924Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000623 AC: 2AN: 32084Hom.: 0 AF XY: 0.0000528 AC XY: 1AN XY: 18924
GnomAD4 exome AF: 0.0000105 AC: 12AN: 1144858Hom.: 0 Cov.: 30 AF XY: 0.00000903 AC XY: 5AN XY: 553980
GnomAD4 genome AF: 0.0000200 AC: 3AN: 150036Hom.: 0 Cov.: 31 AF XY: 0.0000409 AC XY: 3AN XY: 73316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | The c.31G>A (p.A11T) alteration is located in exon 1 (coding exon 1) of the VEGFB gene. This alteration results from a G to A substitution at nucleotide position 31, causing the alanine (A) at amino acid position 11 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at